Drug Type miRNA |
Synonyms T-155 |
Target |
Mechanism miR-155 antagonists(microRNA 155 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | CN | 06 Feb 2023 | |
Choroidal Neovascularization | Preclinical | CN | 01 Aug 2022 |